-
1.
公开(公告)号:US20120093725A1
公开(公告)日:2012-04-19
申请号:US13259802
申请日:2009-04-10
申请人: Jean-Baptiste Michel , Didier Letourneur , Frederic Chaubet , Laure Bachelet , Francois Rouzet , Alain Meulemans
发明人: Jean-Baptiste Michel , Didier Letourneur , Frederic Chaubet , Laure Bachelet , Francois Rouzet , Alain Meulemans
IPC分类号: A61K51/04 , A61P7/02 , A61P9/10 , A61P25/00 , G01N21/78 , A61P35/00 , A61P35/04 , A61P29/00 , G01N33/82 , C07F13/00 , A61P25/28
CPC分类号: A61K49/0002 , A61K49/0054 , A61K49/0442 , A61K49/085 , A61K49/126 , A61K49/1863 , A61K49/223 , A61K49/227 , A61K51/065 , B82Y5/00 , G01N33/534
摘要: The present invention relates to the diagnosis of clinical conditions characterized by undesirable and/or abnormal selectin expression. In particular, the invention provides for the use of fucoidans for the detection of selectins using imaging techniques including ultrasonography, scintigraphy and MRI. Selectin-targeted imaging agents are provided that comprise at least one fucoidan moiety associated with at least one detectable moiety. Methods and kits are described for using these imaging agents in the diagnosis of clinical conditions such as thrombosis, myocardial ischemia/reperfusion injury, stroke and ischemic brain trauma, neurodegenerative disorders, tumor metastasis and tumor growth, and rheumatoid arthritis.
摘要翻译: 本发明涉及以不良和/或异常选择素表达为特征的临床病症的诊断。 特别地,本发明提供了使用岩藻多糖用于使用包括超声,闪烁扫描和MRI的成像技术检测选择素的用途。 提供选择性靶向成像剂,其包含与至少一个可检测部分相关联的至少一个岩藻依聚糖部分。 描述了使用这些成像剂来诊断临床病症如血栓形成,心肌缺血/再灌注损伤,中风和缺血性脑损伤,神经变性障碍,肿瘤转移和肿瘤生长以及类风湿性关节炎的方法和试剂盒。
-
公开(公告)号:US20100221301A1
公开(公告)日:2010-09-02
申请号:US12681676
申请日:2008-10-10
CPC分类号: A61L27/56 , A61L27/20 , A61L27/3804 , A61L27/3826 , A61L27/3834 , A61L27/3847 , A61L27/3852 , A61L27/507 , A61L27/52 , A61L27/54 , A61L2300/21 , A61L2430/02 , A61L2430/06 , C08B37/0018 , C08B37/0021 , C08B37/003 , C08B37/0039 , C08B37/0054 , C08B37/0063 , C08B37/0072 , C08B37/0075 , C08B37/0084 , C08H1/06 , C08J3/24 , C08J9/28 , C08J2201/026 , C08J2201/0484 , C08J2205/04 , C08J2207/10 , C08J2305/00 , C08J2305/02 , C08J2305/08 , C08J2305/12 , C12N5/0068 , C12N11/10 , C12N2533/70 , Y10T436/147777
摘要: The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprise the steps consisting of a) preparing an alkaline aqueous solution comprising an amount of at least one polysaccharide and one cross-linking agent b) freezing the aqueous solution of step a) c) sublimating the frozen solution of step b). characterized in that step b) is performed before the cross-linking of the polysaccharide occurs in the solution of step a).
摘要翻译: 本发明涉及一种用于组织工程的多孔支架的制备方法。 本发明的另一个目的是提供可通过上述方法获得的多孔支架及其在组织工程,细胞培养和细胞递送中的应用。 本发明的方法包括以下步骤:a)制备含有至少一种多糖和一种交联剂的碱性水溶液b)冷冻步骤a)的水溶液c)升华步骤b的冷冻溶液 )。 其特征在于在步骤a)的溶液中发生多糖的交联之前进行步骤b)。
-
公开(公告)号:US09028857B2
公开(公告)日:2015-05-12
申请号:US12681676
申请日:2008-10-10
IPC分类号: A61F13/00 , C07H1/00 , C08B37/02 , A61L27/20 , A61L27/38 , A61L27/50 , A61L27/52 , A61L27/56 , C12N5/00 , C08B37/00 , C08B37/08 , C08H1/06 , C08J9/28
CPC分类号: A61L27/56 , A61L27/20 , A61L27/3804 , A61L27/3826 , A61L27/3834 , A61L27/3847 , A61L27/3852 , A61L27/507 , A61L27/52 , A61L27/54 , A61L2300/21 , A61L2430/02 , A61L2430/06 , C08B37/0018 , C08B37/0021 , C08B37/003 , C08B37/0039 , C08B37/0054 , C08B37/0063 , C08B37/0072 , C08B37/0075 , C08B37/0084 , C08H1/06 , C08J3/24 , C08J9/28 , C08J2201/026 , C08J2201/0484 , C08J2205/04 , C08J2207/10 , C08J2305/00 , C08J2305/02 , C08J2305/08 , C08J2305/12 , C12N5/0068 , C12N11/10 , C12N2533/70 , Y10T436/147777
摘要: The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprise the steps consisting of a) preparing an alkaline aqueous solution comprising an amount of at least one polysaccharide and one cross-linking agent b) freezing the aqueous solution of step a) c) sublimating the frozen solution of step b). characterized in that step b) is performed before the cross-linking of the polysaccharide occurs in the solution of step a).
摘要翻译: 本发明涉及一种用于组织工程的多孔支架的制备方法。 本发明的另一个目的是提供可通过上述方法获得的多孔支架及其在组织工程,细胞培养和细胞递送中的应用。 本发明的方法包括以下步骤:a)制备含有至少一种多糖和一种交联剂的碱性水溶液b)冷冻步骤a)的水溶液c)升华步骤b的冷冻溶液 )。 其特征在于步骤b)在多糖的交联发生在步骤a)的溶液中之前进行。
-
公开(公告)号:US20120183475A1
公开(公告)日:2012-07-19
申请号:US13346075
申请日:2012-01-09
申请人: Jean-Baptiste Michel , Didier Letourneur , Frederic Chaubet , Laure Bachelet , Francois Rouzet , Alain Meulemans
发明人: Jean-Baptiste Michel , Didier Letourneur , Frederic Chaubet , Laure Bachelet , Francois Rouzet , Alain Meulemans
CPC分类号: A61K51/00 , A61K49/04 , A61K49/0438 , A61K49/06 , A61K49/1863 , A61K49/22 , A61K49/221 , A61K49/223 , A61K51/065 , C08B37/0063 , C08L5/00 , G01N33/53 , G01N33/574 , G01N33/6893 , G01N33/6896 , G01N2333/405 , G01N2333/4724 , G01N2400/00 , G01N2800/102 , G01N2800/28 , G01N2800/32
摘要: The present invention relates to the diagnosis of clinical conditions characterized by undesirable and/or abnormal selectin expression. In particular, the invention provides for the use of fucoidans for the detection of selectins using imaging techniques including ultrasonography, scintigraphy and MRI. Selectin-targeted imaging agents are provided that comprise at least one fucoidan moiety associated with at least one detectable moiety. Methods and kits are described for using these imaging agents in the diagnosis of clinical conditions such as thrombosis, myocardial ischemia/reperfusion injury, stroke and ischemic brain trauma, neurodegenerative disorders, tumor metastasis and tumor growth, and rheumatoid arthritis.
-
公开(公告)号:US06646120B1
公开(公告)日:2003-11-11
申请号:US09367111
申请日:2000-09-26
申请人: Frederic Chaubet , Remi Huynh , Latifa Dahri , Jose Correia , Marcel Jozefowicz , Jacqueline Jozefonvicz
发明人: Frederic Chaubet , Remi Huynh , Latifa Dahri , Jose Correia , Marcel Jozefowicz , Jacqueline Jozefonvicz
IPC分类号: C08B3702
CPC分类号: C08B37/0021
摘要: The invention concerns dextran derivatives, their applications as medicines with specific biological action, and their preparation method. Said derivatives correspond to the general formula DMCaBbSUcSd, in which: D represents a polysaccharide chain, preferably consisting of sequences of glucoside units, MC represents methylcarboxylate groups, B represents carboxymethylbenzylamide groups, Su represents sulphate groups, S represents sulphonate groups, a, b, c and d represent the degree of substitution (ds), respectively in groups, MC, B, Su and S; a being equal to 0 or ≧0.3, b being equal to 0 or ≧0.1, c being equal to 0 or ≧0.1 and d being equal to 0 or ≧0.1 provided that when d=0, a and/or b are not equal to 0, said products having homogeneity of chain size distribution, illustrated by a gauss elution profile symmetrical in high performance steric exclusion chromatography, and homogeneity in the distribution of charged chemical groups, illustrated by an elution profile with a single symmetrical peak in low pressure ion-exchange chromatography.
摘要翻译: 本发明涉及葡聚糖衍生物,它们作为具有特定生物作用的药物的应用及其制备方法。 所述衍生物对应于通式DMCaBbSUcSd,其中:D表示多糖链,优选由葡萄糖苷单元序列组成,MC表示甲基羧酸酯基,B表示羧甲基苄基酰胺基,Su表示硫酸基,S表示磺酸酯基,a,b, c和d分别代表组,MC,B,Su和S的取代度(ds); a等于0或> = 0.3,b等于0或> = 0.1,c等于0或> = 0.1,d等于0或> = 0.1,条件是当d = 0时,a和/或 b不等于0,所述产物具有链尺寸分布的均匀性,由高效空间排阻色谱中对称的高斯洗脱曲线所示,以及带电化学基团分布的均匀性,通过具有单个对称峰的洗脱曲线 在低压离子交换层析中。
-
公开(公告)号:US06028191A
公开(公告)日:2000-02-22
申请号:US11750
申请日:1998-05-06
申请人: Alain Nardella , Frederic Chaubet , Corinne Sinquin , Sylvia Colliec Jouault , Catherine Boisson-Vidal , Patrick Durand , Jacqueline Jozefonvicz
发明人: Alain Nardella , Frederic Chaubet , Corinne Sinquin , Sylvia Colliec Jouault , Catherine Boisson-Vidal , Patrick Durand , Jacqueline Jozefonvicz
IPC分类号: C08B37/00
CPC分类号: C08B37/006
摘要: A method for obtaining sulphated polysaccharides using the free radical depolymerization of a fucan from Phaeophyceae in the presence of a metal catalyst and of hydrogen peroxide is described. The method of the invention provides polysaccharide fractions with a molecular weight of 10,000 g/mol or less, with anticoagulant properties.
摘要翻译: PCT No.PCT / FR96 / 01314 Sec。 371日期:1998年5月6日 102(e)日期1998年5月6日PCT提交1996年8月23日PCT公布。 出版物WO97 / 08206 日期1997年3月6日描述了在金属催化剂和过氧化氢存在下,使用从Phaeophyceae获得的福克斯的自由基解聚获得硫酸化多糖的方法。 本发明的方法提供分子量为10,000g / mol以下的具有抗凝血性质的多糖级分。
-
-
-
-
-